These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 21264843)
1. Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer. Holzbeierlein JM Cancer; 2011 Jul; 117(13):2830-2. PubMed ID: 21264843 [No Abstract] [Full Text] [Related]
2. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months. Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T; Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219 [TBL] [Abstract][Full Text] [Related]
3. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study. Nieder AM; Porter MP; Soloway MS J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517 [TBL] [Abstract][Full Text] [Related]
4. Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer. Arcangeli G; Strigari L; Arcangeli S; Petrongari MG; Saracino B; Gomellini S; Papalia R; Simone G; De Carli P; Gallucci M Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):975-82. PubMed ID: 19395188 [TBL] [Abstract][Full Text] [Related]
5. Impact of adjuvant androgen deprivation therapy after radical prostatectomy on the survival of patients with pathological T3b prostate cancer. Siddiqui SA; Boorjian SA; Blute ML; Rangel LJ; Bergstralh EJ; Karnes RJ; Frank I BJU Int; 2011 Feb; 107(3):383-8. PubMed ID: 21265985 [TBL] [Abstract][Full Text] [Related]
6. Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above. Kupelian PA; Buchsbaum JC; Elshaikh M; Reddy CA; Zippe C; Klein EA Cancer; 2002 Dec; 95(11):2302-7. PubMed ID: 12436435 [TBL] [Abstract][Full Text] [Related]
8. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores. Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457 [TBL] [Abstract][Full Text] [Related]
9. Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients. Cozzarini C; Montorsi F; Fiorino C; Alongi F; Bolognesi A; Da Pozzo LF; Guazzoni G; Freschi M; Roscigno M; Scattoni V; Rigatti P; Di Muzio N Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):966-74. PubMed ID: 19619960 [TBL] [Abstract][Full Text] [Related]
10. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. D'Amico AV; Whittington R; Malkowicz SB; Cote K; Loffredo M; Schultz D; Chen MH; Tomaszewski JE; Renshaw AA; Wein A; Richie JP Cancer; 2002 Jul; 95(2):281-6. PubMed ID: 12124827 [TBL] [Abstract][Full Text] [Related]
11. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy. Paparel P; Cronin AM; Savage C; Scardino PT; Eastham JA Eur Urol; 2009 Feb; 55(2):404-10. PubMed ID: 18639970 [TBL] [Abstract][Full Text] [Related]
12. Long-term results of adjuvant hormonal therapy plus radiotherapy following radical prostatectomy for patients with pT3N0 or pT3N1 prostate cancer. Miyake H; Sakai I; Harada K; Hara I; Eto H Int J Urol; 2004 Jun; 11(6):397-401. PubMed ID: 15157209 [TBL] [Abstract][Full Text] [Related]
13. Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer. Wieder JA; Soloway MS J Urol; 1998 Aug; 160(2):299-315. PubMed ID: 9679867 [TBL] [Abstract][Full Text] [Related]
15. Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy). Tewari A; Raman JD; Chang P; Rao S; Divine G; Menon M Urology; 2006 Dec; 68(6):1268-74. PubMed ID: 17169648 [TBL] [Abstract][Full Text] [Related]
16. Impact of percent positive random biopsies on biochemical outcome in prostate cancer patients treated with external beam radiotherapy with or without androgen deprivation. Igdem S; Abacioglu U; Cetin I; Alco G; Akgun Z; Sengoz M; Bekiroglu N; Turkan S; Okkan S J BUON; 2009; 14(4):629-34. PubMed ID: 20148454 [TBL] [Abstract][Full Text] [Related]
17. The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy. Mayer FJ; Crawford ED Urol Clin North Am; 1994 Nov; 21(4):707-15. PubMed ID: 7974899 [TBL] [Abstract][Full Text] [Related]
19. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE. Elliott SP; Meng MV; Elkin EP; McAninch JW; Duchane J; Carroll PR; J Urol; 2007 Aug; 178(2):529-34; discussion 534. PubMed ID: 17570425 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic options for localized carcinoma of the prostate: the role of external beam radiation therapy. Khil MS; Kim JH Henry Ford Hosp Med J; 1992; 40(1-2):103-7. PubMed ID: 1428958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]